PE-backed ProPharma Group buys The Weinberg Group

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired Washington D.C.-based The Weinberg Group Inc, a provider of regulatory and compliance services to the pharmaceutical, biotech and medical device industries. No financial terms were disclosed.

28 January 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles